GCAR1
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GCAR1, covering 2025-04-10 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours [Phase 1]